Starpharma Holdings Ltd (SPL) - Total Assets

Latest as of December 2025: AU$26.17 Million AUD ≈ $18.51 Million USD

Based on the latest financial reports, Starpharma Holdings Ltd (SPL) holds total assets worth AU$26.17 Million AUD (≈ $18.51 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Starpharma Holdings Ltd's book value for net asset value and shareholders' equity analysis.

Starpharma Holdings Ltd - Total Assets Trend (2000–2025)

This chart illustrates how Starpharma Holdings Ltd's total assets have evolved over time, based on quarterly financial data.

Starpharma Holdings Ltd - Asset Composition Analysis

Current Asset Composition (June 2025)

Starpharma Holdings Ltd's total assets of AU$26.17 Million consist of 88.8% current assets and 11.3% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$15.10 Million	60.6%
Accounts Receivable	AU$4.22 Million	16.6%
Inventory	AU$1.92 Million	7.5%
Property, Plant & Equipment	AU$2.86 Million	11.3%
Intangible Assets	AU$0.00	0.0%
Goodwill	AU$0.00	0.0%

Asset Composition Trend (2000–2025)

This chart illustrates how Starpharma Holdings Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Starpharma Holdings Ltd worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Starpharma Holdings Ltd's current assets represent 88.8% of total assets in 2025, a decrease from 99.6% in 2000.
Cash Position: Cash and equivalents constituted 60.6% of total assets in 2025, down from 96.7% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
Asset Diversification: The largest asset category is cash and equivalents at 60.6% of total assets.

Starpharma Holdings Ltd Competitors by Total Assets

Key competitors of Starpharma Holdings Ltd based on total assets are shown below.

Company	Country	Total Assets
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$7.59 Billion
Ascendis Pharma AS F:A71	Germany	€1.30 Billion
Summit Therapeutics PLC NASDAQ:SMMT	USA	$261.73 Million
Xiamen Amoytop Biotech Co Ltd SHG:688278	China	CN¥3.21 Billion
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	China	CN¥6.69 Billion
Wuhan Keqian Biology Co Ltd SHG:688526	China	CN¥4.75 Billion
R&G PharmaStudies Co. Ltd. A SHE:301333	China	CN¥2.31 Billion
Shanghai Shen Lian Biomedical Corp SHG:688098	China	CN¥1.56 Billion

Starpharma Holdings Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	5.26	5.41	10.30
Quick Ratio	4.86	4.93	10.20
Cash Ratio	3.96	4.18	9.56
Working Capital	AU$19.63 Million	AU$21.40 Million	AU$68.35 Million

Starpharma Holdings Ltd - Advanced Valuation Insights

This section examines the relationship between Starpharma Holdings Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	9.78
Latest Market Cap to Assets Ratio	8.49
Asset Growth Rate (YoY)	-30.9%
Total Assets	AU$25.42 Million
Market Capitalization	$215.93 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Starpharma Holdings Ltd's assets at a significant premium (8.49x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: Starpharma Holdings Ltd's assets decreased by 30.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Starpharma Holdings Ltd (2000–2025)

The table below shows the annual total assets of Starpharma Holdings Ltd from 2000 to 2025.

Year	Total Assets	Change
2025-06-30	AU$25.42 Million ≈ $17.99 Million	-30.95%
2024-06-30	AU$36.81 Million ≈ $26.05 Million	-29.32%
2023-06-30	AU$52.09 Million ≈ $36.85 Million	-21.29%
2022-06-30	AU$66.17 Million ≈ $46.82 Million	-9.64%
2021-06-30	AU$73.24 Million ≈ $51.82 Million	+87.41%
2020-06-30	AU$39.08 Million ≈ $27.65 Million	-20.02%
2019-06-30	AU$48.86 Million ≈ $34.57 Million	-16.50%
2018-06-30	AU$58.51 Million ≈ $41.40 Million	-12.13%
2017-06-30	AU$66.59 Million ≈ $47.12 Million	+12.79%
2016-06-30	AU$59.04 Million ≈ $41.77 Million	+33.02%
2015-06-30	AU$44.38 Million ≈ $31.40 Million	+20.40%
2014-06-30	AU$36.86 Million ≈ $26.08 Million	-24.07%
2013-06-30	AU$48.55 Million ≈ $34.35 Million	-10.54%
2012-06-30	AU$54.27 Million ≈ $38.40 Million	+82.06%
2011-06-30	AU$29.81 Million ≈ $21.09 Million	-20.66%
2010-06-30	AU$37.57 Million ≈ $26.58 Million	+30.23%
2009-06-30	AU$28.85 Million ≈ $20.41 Million	+17.01%
2008-06-30	AU$24.65 Million ≈ $17.44 Million	-18.97%
2007-06-30	AU$30.42 Million ≈ $21.53 Million	+21.63%
2006-06-30	AU$25.01 Million ≈ $17.70 Million	+100.11%
2005-06-30	AU$12.50 Million ≈ $8.84 Million	-32.40%
2004-06-30	AU$18.49 Million ≈ $13.08 Million	+72.56%
2003-06-30	AU$10.72 Million ≈ $7.58 Million	-43.18%
2002-06-30	AU$18.86 Million ≈ $13.34 Million	-27.53%
2001-06-30	AU$26.03 Million ≈ $18.41 Million	-10.42%
2000-06-30	AU$29.05 Million ≈ $20.56 Million	--

About Starpharma Holdings Ltd

AU:SPL Australia Biotechnology

Market Cap

$215.93 Million

AU$305.17 Million AUD

Market Cap Rank

#16278 Global

#464 in Australia

Share Price

AU$0.73

Change (1 day)

-2.03%

52-Week Range

AU$0.09 - AU$0.75

All Time High

AU$2.49